Purification of recombinant Aβ(1-42) and pGlu-Aβ(3-42) using preparative SDS-PAGE

Electrophoresis. 2017 Aug;38(16):2042-2049. doi: 10.1002/elps.201700154. Epub 2017 Jun 8.

Abstract

Recombinant expression and purification of amyloid peptides represents a common basis for investigating the molecular mechanisms of amyloid formation and toxicity. However, the isolation of the recombinant peptides is hampered by inefficient separation from contaminants such as the fusion protein required for efficient expression in E. coli. Here, we present a new approach for the isolation of highly purified Aβ(1-42) and pGlu-Aβ(3-42), which is based on a separation using preparative SDS-PAGE. The method relies on the purification of the Aβ fusion protein by affinity chromatography followed by preparative SDS-PAGE under reducing conditions and subsequent removal of detergents by precipitation. The application of preparative SDS-PAGE represents the key step to isolate highly pure recombinant Aβ, which has been applied for characterization of aggregation and toxicity. Thereby, the yield of the purification strategy was >60%. To the best of our knowledge, this is the first description of an electrophoresis-based method for purification of a recombinant Aβ peptide. Therefore, the method might be of interest for isolation of other amyloid peptides, which are critical for conventional purification strategies due to their aggregation propensity.

Keywords: Alzheimer's disease; Amyloid; Aβ; Neurodegeneration; Preparative SDS-PAGE.

MeSH terms

  • Amyloid beta-Peptides / isolation & purification*
  • Amyloid beta-Peptides / pharmacology
  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Chromatography, Affinity
  • Electrophoresis, Polyacrylamide Gel
  • Escherichia coli / genetics
  • Humans
  • Mass Spectrometry
  • Mice
  • Microscopy, Electron, Transmission
  • Neurons / cytology
  • Peptide Fragments / isolation & purification*
  • Peptide Fragments / pharmacology
  • Recombinant Fusion Proteins / isolation & purification*
  • Recombinant Fusion Proteins / pharmacology

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Recombinant Fusion Proteins
  • amyloid beta-protein (1-42)
  • amyloid beta-protein (3-42), pyroglutamyl(3)-